Healthcare IT technology provider ClearData has closed an oversubscribed series C round featuring existing investors Merck and Norwest Venture Partners.

Pharmaceutical firm Merck’s Global Health Innovation Fund backed an oversubscribed $25m series C round closed by US-based healthcare IT company ClearData yesterday.

The round was co-led by venture capital firms Heritage Group, HLM Venture Partners and Flare Capital Partners, and also featured Norwest Venture Partners, a VC affiliate of financial services provider Wells Fargo, and VC firm Excel Venture Management.

ClearData’s cloud infrastructure technology enables healthcare companies to use the cloud securely. The series C funding will be used to…